Profits/NNS slide/NN at/IN India's/NNP Dr/NNP Reddy/NNP

Profits/NNS at/IN Indian/JJ drugmaker/NN Dr/NNP Reddy's/NNP fell/VBD 93%/CD as/IN research/NN costs/NNS rose/VBD and/CC sales/NNS flagged./NN

The/DT firm/NN said/VBD its/PRP$ profits/NNS were/VBD 40m/CD rupees/NNS ($915000/CD Â£486000)/CD for/IN the/DT three/CD months/NNS to/TO December/NNP on/IN sales/NNS which/WDT fell/VBD 8%/CD to/TO 4.7bn/CD rupees./NN
Dr/NNP Reddy's/NNP has/VBZ built/VBN its/PRP$ reputation/NN on/IN producing/VBG generic/JJ versions/NNS of/IN big-name/JJ pharmaceutical/JJ products./NN
But/CC competition/NN has/VBZ intensified/VBN and/CC the/DT firm/NN and/CC the/DT company/NN is/VBZ short/JJ on/IN new/JJ product/NN launches./NN
The/DT most/RBS recent/NN was/VBD the/DT annoucement/NN in/IN December/NNP 2000/CD that/IN it/PRP had/VBD won/VBN exclusive/JJ marketing/NN rights/NNS for/IN a/DT generic/JJ version/NN of/IN the/DT famous/JJ anti-depressant/JJ Prozac/NNP from/IN its/PRP$ maker/NN Eli/NNP Lilly./NNP
It/PRP also/RB lost/VBD a/DT key/JJ court/NN case/NN in/IN March/NNP 2004/CD banning/VBG it/PRP from/IN selling/VBG a/DT version/NN of/IN Pfizer's/NNP popular/JJ hypertension/NN drug/NN Norvasc/NNP in/IN the/DT US./NNP
Research/NNP and/CC development/NN of/IN new/JJ drugs/NNS is/VBZ continuing/VBG apace/NN with/IN R&D/NNP spending/NN rising/VBG 37%/CD to/TO 705m/CD rupees/NNS -/: a/DT key/JJ cause/NN of/IN the/DT decrease/NN in/IN profits/NNS alongside/IN the/DT fall/NN in/IN sales./NN
Patents/NNP on/IN a/DT number/NN of/IN well-known/JJ products/NNS are/VBP due/JJ to/TO run/VB out/RP in/IN the/DT near/JJ future/JJ representing/NN an/DT opportunity/NN for/IN Dr/NNP Reddy/NNP whose/WP$ shares/NNS are/VBP listed/VBN in/IN New/NNP York/NNP and/CC other/JJ Indian/JJ generics/NNS manufacturers./NN

Sales/NNS in/IN Dr/NNP Reddy's/NNP generics/NNS business/NN fell/VBD 8.6%/CD to/TO 966m/CD rupees./NN
Another/DT staple/NN of/IN the/DT the/DT firm's/NNS business/VBP the/DT sale/NN of/IN ingredients/NNS for/IN drugs/NNS also/RB performed/VBN poorly./NN
Sales/NNS were/VBD down/RB more/JJR than/IN 25%/CD from/IN the/DT previous/JJ year/NN to/TO 1.4bn/CD rupees/NNS in/IN the/DT face/NN of/IN strong/JJ competition/NN both/DT at/IN home/NN and/CC in/IN the/DT US/PRP and/CC Europe./NNP
Dr/NNP Reddy's/NNP Indian/JJ competitors/NNS are/VBP gathering/VBG strength/NN although/IN they/PRP too/RB face/VBP heavy/JJ competitive/JJ pressures./NN